P38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats

Journal of Hypertension

Volumn 27, Issue 1, 2009, Pages 142-154

  Beltrán, Amada E ^a   Briones, Ana M ^a   García Redondo, Ana B ^a   Rodríguez, Cristina ^c   Miguel, Marta ^a   Álvarez, Yolanda ^a   Alonso, María J ^a,b   Martínez González, José ^c   Salaices, Mercedes ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Angiotensin; Cyclooxygenase 2; Fibroblasts; Hypertension; Mitogen activated protein kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALLOPURINOL; ANGIOTENSIN II; APOCYNIN; CATALASE; CYCLOOXYGENASE 2; ENZYME INHIBITOR; HYDROETHIDINE; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; OXYGEN; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; TEMPOL; VALSARTAN; XANTHINE OXIDASE INHIBITOR; PTGS2 PROTEIN, RAT; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME IMMUNOASSAY; ENZYME PHOSPHORYLATION; ESSENTIAL HYPERTENSION; FIBROBLAST; FIBROBLAST CULTURE; FLUORESCENCE; MALE; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; ENZYMOLOGY; GENETICS; HYPERTENSION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; AORTA; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLASTS; HYPERTENSION; MALE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUPEROXIDES;

EID: 58849099214     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328317a730     Document Type: Article

References (48)

1. McGrath JC, Deighan C, Briones AM, Shafaroudi MM, McBride M, Adler J, et al. New aspects of vascular remodelling: the involvement of all vascular cell types. Exp Physiol 2005; 90:469-475.
2. Somoza B, Gonza'lez MC, Gonza'lez JM, Abderrahim F, Arribas SM, Fernandez-Alfonso MS. Modulatory role of the adventitia on noradrenaline and angiotensin II responses. Role of endothelium and AT2 receptors. Cardiovasc Res 2005; 65:478-486.
3. Haurani MJ, Pagano PJ. Adventitial ?broblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease? Cardiovasc Res 2007; 75:679-689.
4. Vagnoni KE, Christiansen ND, Holyoak GR, Janowiak MA, Martin PH. Cellular source in ewes of prostaglandin-endoperoxide synthase-2 in uterine arteries following stimulation with lipopolysaccharide. Biol Reprod 1999; 61:563-568.
5. Hernanz R, Alonso MJ, Briones AM, Vila E, Simonsen U, Salaices M. Mechanisms involved in the early increase of serotonin contraction evoked by endotoxin in rat middle cerebral arteries. Br J Pharmacol 2003; 140:671-680.
6. Briones AM, Salaices M, Vila E. Ageing alters the production of nitric oxide and prostanoids after IL-1b exposure in mesenteric resistance arteries. Mech Ageing Dev 2005; 126:710-721.
7. Adeagbo AS, Zhang X, Patel D, Joshua IG, Wang Y, Sun X, et al. Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension. J Hypertens 2005; 23:1025-1036.
8. A Lvarez Y, Briones AM, Balfago'n G, Alonso MJ, Salaices M. ypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens 2005; 23:767-777.
9. Antman EM, DeMets D, Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation 2005; 112:759-770.
10. Garc'a-Cohen EC, Mar'nJ, D'ez-Picazo LD, Baena AB, Salaices M, Rodr'guez-Mart'nez MA. Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoform. J Pharmacol Exp Ther 2000; 293:75-81.
11. Tabernero A, Reimund JM, Chasserot S, Muller CD, Andriantsitohaina R. Cyclooxygenase-2 expression and role of vasoconstrictor prostanoids in small mesenteric arteries from patients with Crohn's disease. Circulation 2003; 107:1407-1410.
12. Ruiz-Ortega M, Esteban V, Rupe'rez M, Sanchez-Lopez E, Rodr?guez-Vita J, Carvajal G, et al. Renal and vascular hypertension-induced in?ammation: role of angiotensin II. Curr Opin Nephrol Hypertens 2006; 15:159-166.
13. Freeman EJ, Ruehr ML, Dorman RV. Ang II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells. Am J Physiol 1998; 274:C282-C288.
14. Ohnaka K, Numaguchi K, Yamakawa T, Inagami T. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 2000; 35:68-75.
15. Hu ZW, Kerb R, Shi XY, Wei-Lavery T, Hoffman BB. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 2002; 303:563-573.
16. Scheuren N, Jacobs M, Ertl G, Schorb W. Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac ?broblasts and role at acute myocardial infarction. J Mol Cell Cardiol 2002; 34:29-37.
17. Harris RC, Zhang MZ, Cheng HF. Cyclooxygenase-2 and the renal renin-angiotensin system. Acta Physiol Scand 2004; 181:543-547.
18. Jiang B, Xu S, Hou X, Pimentel DR, Cohen RA. Angiotensin II differentially regulates interleukin-1-b-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. J Biol Chem 2004; 279:20363-20368.
19. Slice LW, Chiu T, Rozengurt E. Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways. J Biol Chem 2005; 280:1582-1593.
20. McGinty A, Foschi M, Chang YW, Han J, Dunn MJ, Sorokin A. Induction of prostaglandin endoperoxide synthase 2 by mitogen-activated protein kinase cascades. Biochem J 2000; 352:419-424.
21. Feng L, Xia Y, Garc?a GE, Hwang D, Wilson CB. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-a and lipopolysaccharide. J Clin Invest 1995; 95:1669-1675.
22. Peng T, Lu X, Feng Q. NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes. FASEB J 2005; 19:293-295.
23. Kim DK, Huh JE, Lee SH, Hong KP, Park JE, Seo JD, et al. Angiotensin II stimulates proliferation of adventitial ?broblasts cultured from rat aortic explants. J Korean Med Sci 1999; 14:487-496.
24. Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S. Myo?broblasts differentiate from ?broblasts when plated at low density. Proc Natl Acad Sci USA 1996; 93:4219-4223.
25. Martorell L, Mart?nez-Gonza'lez J, Crespo J, Calvayrac O, Badimon L. Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth. J Thromb Haemost 2007; 5:1766-1773.
26. Pham H, Chong B, Vincenti R, Slice LW. Ang II and EGF synergistically induce COX-2 expression via CREB in intestinal epithelial cells. JCell Physiol 2008; 214:96-109.
27. Wadleigh DJ, Herschman HR. Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts. Biochem Biophys Res Commun 1999; 264:865-870.
28. Wu KK. Differential cyclooxygenase-2 transcriptional control in roliferating versus quiescent ?broblasts. Prostaglandins Other Lipid Mediat 2007; 83:175-181.
29. Jaimes EA, Tian RX, Pearse D, Raij L. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int 2005; 68:2143-2153.
30. RebsamenMC, Capoccia R, Vallotton MB, Lang U. Role of cyclooxygenase 2, p38 and p42/44 MAPK in the secretion of prostacyclin induced by epidermal growth factor, endothelin-1 and angiotensin II in rat ventricular cardiomyocytes. J Mol Cell Cardiol 2003; 35:81-89.
31. A'lvarez Y, Pe'rez JV, Hernanz R, Briones AM, Garc?a-Redondo A, Beltran A, et al. Losartan reduces the increased participation of COX-2 derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther 2007; 321:381-388.
32. Jaimes EA, Zhou MS, Pearse DD, Puzis L, Raij L. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. Am J Physiol Renal Physiol 2008; 294:F385-392.
33. Zhang MZ, Yao B, Cheng HF, Wang SW, Inagami T, Harris RC. Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT1 and AT2 receptors. Proc Natl Acad Sci USA 2006; 103:16045-16050.
34. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA 1997; 94:14483-14488.
35. Chamseddine AH, Miller FJ Jr. Gp91phox contributes to NADPH oxidase activity in aortic ?broblasts but not smooth muscle cells. Am J Physiol Heart Circ Physiol 2003; 285:H2284-H2289.
36. Shen WL, Gao PJ, Che ZQ, Ji KD, Yin M, Yan C, et al. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial ?broblast phenotypic differentiation. Biochem Biophys Res Commun 2006; 339:337-343.
37. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006; 71:247-258.
38. Zhang H, Schmeisser A,Garlichs CD, Plotze K, Damme U,Mugge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 1999; 44:215-222.
39. Puntmann VO, Hussain MB, Mayr M, Xu Q, Singer DR. Role of oxidative stress in angiotensin-II mediated contraction of human conduit arteries in patients with cardiovascular disease. Vascul Pharmacol 2005; 43:277-282.
40. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 2003; 285:H2290-H2297.
41. Li J,Chen YJ,Quilley J. Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat. J Pharmacol Exp Ther 2005; 314:818-824.
42. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 1996; 8:205-215.
43. Li L, Zhu DL, ShenWL, Gao PJ. Increased migration of vascular adventitial ?broblasts from spontaneously hypertensive rats. Hypertens Res 2006; 29:95-103.
44. Tabet F, Schiffrin EL, Touyz RM.Mitogen-activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase-dependent, protein kinase C-independent pathways in vascular smooth muscle cells: upregulation in spontaneously hypertensive rats. J Hypertens 2005; 23:2005-2012.
45. Moreno-Aliaga MJ, Stanhope KL, Gregoire FM, Warden CH, Havel PJ.Effects of inhibiting transcription and protein synthesis on basal and insulin-stimulated leptin gene expression and leptin secretion in cultured rat adipocytes. Biochem Biophys Res Commun 2003; 307:907-914.
46. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 2000; 20:4265-4274.
47. Doller A, Akool el-S, Huwiler A, Muller R, Radeke HH, Pfeilschifter J, EberhardtW. Posttranslational modi?cation of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol 2008; 28:2608-2625.
48. Cok SJ, Morrison AR. The 30-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational ef?ciency. J Biol Chem 2001; 276:23179-23185.